Lung cancer remains the leading cause of cancer-related death in Canada, claiming nearly 21,000 lives in 2024. In response, ...

Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer ...

MGC028, the intervention being tested, is a biological treatment designed to target and combat advanced solid tumors by leveraging its action against the ADAM9 protein. The study follows a ...

Advances in systemic and local therapies are helping more live longer with liver cancer and move forward after treatment as ...

The study is testing INBRX-106, a hexavalent OX40 agonist antibody, designed to enhance the immune response against tumors. It is administered alone or with pembrolizumab, a well-known anti-PD-1 ...

Some women undergo unnecessary mastectomy and chemotherapy, but a "labyrinth in a chip" could reveal which cancers need ...

Data from an exploratory analysis of the pivotal phase 3 MIRASOL trial (NCT04209855) were recently unveiled at the 2025 European Society for Medical Oncology (ESMO) Congress, opening a broader ...

Over the past generation, advances in treating common cancers—breast, lung, melanoma, and gastrointestinal (GI)—have improved ...

Prostate cancer screening could prevent around 1,500 deaths a year in the UK, research suggests. A European trial, one of the ...

Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Study Overview: Shanghai ...

University of Wisconsin’s Carbone Cancer Center recently announced a partnership with TAE Life Sciences, a company that ...